MacroGenics, Inc. (MGNX)
4.08
+0.04
(+0.99%)
USD |
NASDAQ |
Aug 27, 15:51
MacroGenics Market Cap : 259.67M for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 257.13M |
| August 25, 2026 | 265.40M |
| August 24, 2026 | 255.86M |
| August 21, 2026 | 260.95M |
| August 20, 2026 | 259.04M |
| August 19, 2026 | 265.40M |
| August 18, 2026 | 260.31M |
| August 17, 2026 | 258.40M |
| August 14, 2026 | 268.58M |
| August 13, 2026 | 259.67M |
| August 12, 2026 | 255.86M |
| August 11, 2026 | 249.49M |
| August 10, 2026 | 259.67M |
| August 07, 2026 | 256.78M |
| August 06, 2026 | 254.88M |
| August 05, 2026 | 247.88M |
| August 04, 2026 | 247.88M |
| August 03, 2026 | 242.80M |
| July 31, 2026 | 234.54M |
| July 30, 2026 | 240.26M |
| July 29, 2026 | 233.27M |
| July 28, 2026 | 244.71M |
| July 27, 2026 | 254.24M |
| July 24, 2026 | 235.17M |
| July 23, 2026 | 254.88M |
| Date | Value |
|---|---|
| July 22, 2026 | 273.31M |
| July 21, 2026 | 288.56M |
| July 20, 2026 | 274.58M |
| July 17, 2026 | 285.38M |
| July 16, 2026 | 261.87M |
| July 15, 2026 | 274.58M |
| July 14, 2026 | 272.67M |
| July 13, 2026 | 286.02M |
| July 10, 2026 | 275.22M |
| July 09, 2026 | 290.47M |
| July 08, 2026 | 296.19M |
| July 07, 2026 | 301.91M |
| July 06, 2026 | 290.47M |
| July 02, 2026 | 299.37M |
| July 01, 2026 | 293.65M |
| June 30, 2026 | 293.65M |
| June 29, 2026 | 308.90M |
| June 26, 2026 | 305.72M |
| June 25, 2026 | 296.19M |
| June 24, 2026 | 303.82M |
| June 23, 2026 | 298.10M |
| June 22, 2026 | 291.11M |
| June 18, 2026 | 262.50M |
| June 17, 2026 | 251.70M |
| June 16, 2026 | 246.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 455.21B |
| Gilead Sciences, Inc. | 184.16B |
| Xencor, Inc. | 2.138B |
| Akari Therapeutics Plc | 15.79M |
| Janux Therapeutics, Inc. | 1.145B |
Market Cap Related Metrics
| PS Ratio | 1.543 |
| Price to Book Value | 6.057 |
| Price | 4.08 |
| Earnings Yield | -5.65% |